Lindbrook Capital LLC Sells 396 Shares of The Clorox Company (NYSE:CLX)

Lindbrook Capital LLC reduced its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 40.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 581 shares of the company’s stock after selling 396 shares during the period. Lindbrook Capital LLC’s holdings in Clorox were worth $94,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of CLX. Wealth Group Ltd. bought a new position in shares of Clorox during the 3rd quarter valued at approximately $231,000. QRG Capital Management Inc. bought a new position in shares of Clorox during the 3rd quarter valued at approximately $225,000. Concurrent Investment Advisors LLC grew its position in shares of Clorox by 5.0% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 16,084 shares of the company’s stock valued at $2,620,000 after acquiring an additional 760 shares during the period. Graypoint LLC grew its position in shares of Clorox by 28.0% during the 3rd quarter. Graypoint LLC now owns 3,899 shares of the company’s stock valued at $635,000 after acquiring an additional 854 shares during the period. Finally, Woodmont Investment Counsel LLC purchased a new stake in shares of Clorox during the 3rd quarter valued at approximately $222,000. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

NYSE CLX opened at $151.11 on Friday. The company’s 50 day simple moving average is $155.65 and its two-hundred day simple moving average is $160.34. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a market capitalization of $18.61 billion, a PE ratio of 41.29, a P/E/G ratio of 2.62 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the company posted $2.16 EPS. Analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.23%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is currently 133.33%.

Analyst Ratings Changes

CLX has been the topic of a number of recent research reports. DA Davidson dropped their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. JPMorgan Chase & Co. upped their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Finally, Wells Fargo & Company upped their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $159.62.

Read Our Latest Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.